The pathology imaging systems market is likely to register a CAGR of 10.36% during the forecast period, and is anticipated to reach a pathology imaging systems market share of US$ 2603.74 Million in 2032, from US$ 971.59 Million in 2022.
| Attributes | Details |
|---|---|
| Pathology Imaging Systems Market (CAGR) | 10.36% |
| Pathology Imaging Systems Market (2022) | US$ 971.59 Million |
| Pathology Imaging Systems Market (2032) | US$ 2603.74 Million |
A few of the factors propelling the pathology imaging systems market key trends and opportunities as a whole include rising cancer incidences, rising demand for pathology imaging systems that are better, rising healthcare spending, rising government funding, and rising R&D efforts resulting in escalated sales of pathology imaging systems.
The pathology imaging systems adoption trends are booming due to the growing adoption of pathology imaging systems in hospitals, diagnostic facilities, and research organisations.
Increasing capital investment requirements, as well as a shortage of skilled operators, will act as pathology imaging systems market restraints for the pathology imaging systems market growth over the forecasted timeframe.
Increasingly stringent regulatory compliance, and sampling error, may become the pathology imaging systems market's most pressing challenge.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growing awareness among physicians and patients about the benefits of pathology imaging systems will create lucrative pathology imaging systems market opportunities for pathology imaging systems market growth.
The rising number of patients suffering from chronic diseases such as cancer, the rising demand for pathology imaging systems that are improved, the rising levels of investment in the healthcare sector, the rising popularity of the system in hospitals, diagnostic centres, and research organisations, and the rising trends of tele-pathology are some of the major and vital factors that will likely augment the pathology imaging systems market growth in the forecast timeframe.
On the other hand, the increasing number of technological advancements, as well as the rising adoption of pathology imaging systems, will further contribute to the pathology imaging systems market growth over the forecasted timeframe.
Growth in the tele-pathology trend is another factor driving the pathology imaging systems market future trends along with pathology imaging systems key trends and opportunities. Growth is constrained by high maintenance and capital costs. Pathology imaging systems market expansion is also constrained by a shortage of operators with high levels of skill, strict regulatory compliance, and sampling error.
Principal Consultant
With its high level of technological development and molecular diagnostics research, North America currently dominates the pathology imaging systems market future trends, followed by countries in Western Europe.
Emerging trends in pathology imaging systems market is brought about by high-quality diagnostics, favourable reimbursement conditions; government funding, established players in the pathology imaging systems market, and the availability of trained technicians in these areas accelerate the pathology imaging systems adoption trends.
The Asia Pacific region is anticipated to experience rapid pathology imaging systems market growth over the course of the assessment period. In this region of the world, increased adoption of cutting-edge technologies like digital imaging is anticipated to create new pathology imaging systems market opportunities for the pathology imaging systems market growth.
The next lucrative pathology imaging systems market is anticipated to be Japan. Asia Pacific is leading the pathology imaging systems market in terms of growth rate due to expanding economies, an increase in molecular research activities, an increase in the patient population, and better healthcare opportunities also boosting the pathology imaging systems market trends and forecasts.
The pathology imaging systems market's startup ecosystem is cluttered with new entrants desperately trying to use innovation as a tool for a breakthrough.
December 2020 marks the acquisition of USD 23 million by US-based pathology imaging systems startup Proscia in order to advance Concentriq, a software platform that serves as a basic operating system for digital scanners used to assess tissue biopsies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
There are many established brands and key players in the pathology imaging systems market, which makes it more competitive. Modern technologies are at the forefront of the pathology imaging systems market in this industry.
The pathology imaging systems market growth is also being boosted by strategic alliances and partnerships between businesses and academic institutions. Innovative imaging systems technology was adopted in pathology as a result of significant technological advancements.
GE Healthcare, Leica Biosystems, Perkin Elmer, Siemens, Olympus Corporation, Philips Healthcare, Sakura Finetek, DigiPath, Carl Zeiss Meditec AG, Hamamatsu Photonics, 3D-Histech Ltd., and others are some of the leading companies in the pathology imaging systems market.
Recent Development:
Partnership:
Through Charles River Laboratories International, Inc. and Deciphex Patholytix Preclinical partnership with Deciphex, a pioneer in preclinical digital pathology software-as-a-service, Charles River will optimise Patholytix Preclinical tools in order to use this sector-leading, validated digital peer review process to streamline and hasten the process of guaranteeing the consistency and integrity of studies.
Launch:
FDA approval:
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 10.3% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Historical data | 2016 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in US$ million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Product type, end use, material type, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | GE Healthcare, Leica Biosystems, Perkin Elmer, Siemens, Olympus Corporation, Philips Healthcare, Sakura Finetek, DigiPath, Carl Zeiss Meditec AG, Hamamatsu Photonics, 3D-Histech Ltd. |
| Customization scope | Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The pathology imaging systems market is anticipated to register a CAGR of 10.3% during the forecast period.
The pathology imaging systems market share is anticipated to reach US$ 2128.57 Million by 2030.
The demand for alternative medicines increases with growing belief and awareness which acts as the key driver for the pathology imaging systems market.
North America pathology imaging systems market holds the highest revenue potential.
The pathology imaging systems market size is anticipated to be over US$ 971.59 Million in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Imaging Systems
5.3.2. Accessories and Software
5.3.3. Services
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Clinical Diagnosis
6.3.2. Academic Research
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Research Organizations
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. US
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. US
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By Application
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By Application
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By Application
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By Application
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By Application
14.5.2.3. By End User
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By Application
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By Application
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By Application
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By Application
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By Application
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By Application
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By Application
14.12.2.3. By End User
14.13. GCC Countries
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By Application
14.13.2.3. By End User
14.14. South Africa
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By Application
14.14.2.3. By End User
14.15. Israel
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By Application
14.15.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. GE Healthcare
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Leica Biosystems
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Perkin Elmer
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Siemens
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Olympus Corporation
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Philips Healthcare
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Sakura Finetek
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. DigiPath
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Carl Zeiss Meditec AG
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Hamamatsu Photonics
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.11. 3D-Histech Ltd
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Pathology Imaging Systems Market
